-
Paris), 140 000€ Bourse de Master / PhD track (IP Paris – Centre E4H), 20 000€ Soutien du laboratoire (dotations récurrentes), 20 000€ Soutien de l’équipe, 20 000€ Remuneration package 3 500€ - 5 000
-
authorities. Indicators: 1. Number and quality of scientific output (publications, software, patents, books) 2. Establishment of institutional partnerships formalized by contracts 3. Influence within
-
to studying the determinants of health at different ages, developing innovative methods, and evaluating interventions to improve clinical practices and public health policies. Among its five teams, the OPPaLE
-
innovative biotherapies. Both teams develop high-quality translational research and therapeutic innovation in the field of diseases involving immune disorders with a constant method from the bench to bedside
-
cellular behavior. This includes generating in silico predictions for biological phenomena that remain inaccessible to direct experimentation. Statistical methods and AI approaches are developed and applied
-
) at the University of Bordeaux, as well as to research-based teaching and tutorials linked to Inserm U1034 and IHU VBHI. These activities include the MD–PhD program of Bordeaux University Hospital, Inserm School
-
as well as students enrolled in MD-PhD tracks, within fundamental science modules. The program will combine lectures, case studies drawn from translational research, and critical analyses of recent
-
laboratory financial support is provided Further application to PhD grant will be available Independently of this initial package, candidate might be eligible for start-up programs such as ERC grant
-
project: With strong support from the French Government (through the SFRI program TRITON), “Nantes Université” aims to transform graduate training (from master to PhD) through the development of Graduate
-
process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile: R3/R4 R3 Established researcher A stage in